BackCadrenal Therapeutics Overview

Cadrenal Therapeutics Receivables

Cadrenal Therapeutics's receivables is $5.5K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$5466.00
↓ 77.84% YoYΔ $-19198.00 vs prior year quarter

Peer average

Loading

Cadrenal Therapeutics Receivables History

Loading

Cadrenal Therapeutics vs. peers: Receivables Comparison

Loading

Cadrenal Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cadrenal Therapeutics (CVKD) FAQ

As of the most recent data (March 2026), CVKD shows a receivables of $5.5K. That compares with $25K in the prior-year period — down 77.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CVKD's receivables is now $5.5K (was $25K) — a 77.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cadrenal Therapeutics is outperforming or lagging.

Tracking CVKD's receivables over time shows whether Cadrenal Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $5.5K That compares with $25K in the prior-year period — down 77.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Cadrenal Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $5.5K) with ownership activity and broader fundamentals.